Document |
Document Title |
WO/2023/098612A1 |
A salt form and a crystal form of a dimethyl sulfoximine derivative, and a preparation method therefor. Specifically disclosed are a hydrate, a salt form and crystal form of a compound of formula (I), and a method for preparing the compo...
|
WO/2023/102063A1 |
Platinum group metal containing chemical precursors suitable for vapor deposition are disclosed. Methods of using these precursors for Platinum depositions are also disclosed. The chemical precursors and methods are particularly suitable...
|
WO/2023/099543A1 |
The present invention describes fluorene derivatives substituted by electron-transporting groups, especially for use as hole blocking materials, electron injection materials and/or electron transport materials in electronic devices. The ...
|
WO/2023/094412A1 |
The present invention relates to compounds that are suitable for use in electronic devices, and to electronic devices, more particularly organic electroluminescent devices, containing these compounds.
|
WO/2023/096881A1 |
The present disclosure provides methods of treating a mixed type of produce with a cyclopropene, as well as methods of treating plant or plant parts in an environment comprising exogenous ethylene methods with a cyclopropene. The methods...
|
WO/2023/097167A1 |
Provided in this disclosure are engineered sesquiterpene synthases, host cells expressing engineered sesquiterpene synthases and methods for making alpha-guaiene.
|
WO/2023/090404A1 |
Provided are: a novel condensed ring fluorene compound that facilitates the production of an organic electroluminescent element in which driving the voltage can be reduced; a material for an organic electroluminescent element, the materi...
|
WO/2023/091993A1 |
Provided herein are salts which intercalate into the DNA of a cell and are capable of crossing the blood brain barrier of the formula (I) wherein the variables are as defined herein. These salts may be show improved water solubility and/...
|
WO/2023/086801A1 |
The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 ("TREM2"). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of ...
|
WO/2023/082849A1 |
The present invention provides a plant squalane composition, a preparation method therefor, and the use thereof. The plant squalane composition comprises: at least 92.0 wt% of squalane and 0.5-3.0 wt% of cyclosqualane, wherein wt% is bas...
|
WO/2023/070480A1 |
Disclosed is a halimane diterpenoid in Leucas zeylanica, having a structure as described below, a method for preparing the halimane diterpenoid from Leucas zeylanica, and a use of the halimane diterpenoid in Leucas zeylanica in the prepa...
|
WO/2023/072041A1 |
A hydrogenation-acid catalysis bifunctional catalyst, containing, by using the mass of the catalyst as a reference: 80-99.8% of a silicon-aluminum molecular sieve component, 0.2-2% of a metal component which is loaded on the molecular si...
|
WO/2023/065996A1 |
The present invention relates to an anthracene derivative, an organic electroluminescent material, a light-emitting device, and a consumer product. The anthracene derivative of the present invention is a novel organic electroluminescent ...
|
WO/2023/056010A1 |
Reagents and methods for the design and analysis of reporter probes optimized for various chemoproteomic assays.
|
WO/2023/046050A1 |
Disclosed is a continuous method for preparing exo-tetrahydrodicyclopentadiene by isomerizing endo-tetrahydrodicyclopentadiene. The method comprises: sequentially passing endo-tetrahydrodicyclopentadiene and hydrogen through a first reac...
|
WO/2023/043164A1 |
The present invention relates to an organic compound and an organic light-emitting device comprising same, the organic compound being employed in a light efficiency improvement layer included in an organic light-emitting device, so as to...
|
WO/2023/042819A1 |
The present invention provides a novel composition, etc. The composition contains at least caryophyllene as well as menthol and/or an oil/fat.
|
WO/2023/042820A1 |
Provided are a novel composition and others. This composition contains at least caryophyllene and a fragrance.
|
WO/2023/023671A1 |
The present disclosure is directed to N-(3-substituted-chroman-4-yl)-7H-pyrrolo[2,3- d]pyrimidin-4-amine compounds, methods of making N-(3-substituted-chroman-4-yl)-7H- pyrrolo[2,3-d]pyrimidin-4-amine compounds, and methods of treating d...
|
WO/2023/020531A1 |
A method for synthesizing 5,8-diamino-3,4-dihydro-2H-1-naphthalenone (compound I), which method comprises: subjecting 2,5-diprotected aminophenylbutyric acid to the Friedel-Crafts reaction for ring closure, and then removing a protecting...
|
WO/2023/017704A1 |
The present invention is an organic electroluminescent element (1) having a light-emitting region (5) disposed between a positive electrode (3) and a negative electrode (4). The light-emitting region (5) includes a first light-emitting l...
|
WO/2023/010000A1 |
The invention features indolealkylamine compounds and pharmaceutical compositions useful for treating 5-HT2 responsive conditions. Also provided are methods of using the compounds or compositions of the invention for treating 5-HT2 respo...
|
WO/2023/280295A1 |
A compound of formula (I) or a pharmaceutically acceptable salt, an ester, an isomer, a solvate, a prodrug or an isotope marker thereof. The structure of the compound of formula (I) is: the compound has good inhibitory ability to selecti...
|
WO/2023/280246A1 |
Provided are an organic compound and an application thereof in an organic electronic device, particularly in an organic electroluminescent diode. The present invention also relates to an organic electronic device containing the organic c...
|
WO/2022/270401A1 |
[Problem] To provide, as a new cyclopentadiene production method, a method for producing cyclopentadiene stably over a long period of time at a high yield by using a zeolite catalyst in the presence of an olefin. [Solution] A method for ...
|
WO/2022/270400A1 |
[Problem] The purpose of the present invention is to provide a cyclopentadiene production method which can efficiently produce industrially useful cyclopentadiene from a raw composition that contains a branched hydrocarbon of 5 carbon at...
|
WO/2022/257260A1 |
Provided is a method for industrially manufacturing 1,4-dimethylnaphthalene having low 1,3-dimethylnaphthalene content. In the method for manufacturing 1,4-dimethylnaphthalene, 5-phenyl-2-hexene is cyclized in the presence of an acid cat...
|
WO/2022/257261A1 |
Cyclization of 5-phenyl-2-hexene is controlled to occur at a specified temperature, so as to efficiently prepare 1,4-dimethyltetralin. The present invention provides a method for preparing 1,4-dimethyltetralin, etc., the method comprisin...
|
WO/2022/256363A1 |
Embodiments of the present disclosure are directed towards methods of making an alkylated metallocene having one or more tetrahydropentalenyl groups, the method comprising: reacting a chloride compound with a lithium compound to make a r...
|
WO/2022/247858A1 |
An organic compound having the following structural formula: (I). The organic compound has a good rigid structure, so that the organic compound has good thermal stability, and high efficiency and long service life of an OLED device are r...
|
WO/2022/242582A1 |
Provided herein are an indene compound, e.g., a compound of Formula (I), and a pharmaceutical composition thereof. Also provided herein is a method of their use for treating, preventing, or ameliorating one or more symptoms of a fibrotic...
|
WO/2022/242292A1 |
Provided in the present application is a benzocyclobutene monomer, which has structural formula (I), wherein two R1s are separately independently selected from a hydrogen atom, a methyl group, a methoxy group, an ethyl group, and an este...
|
WO/2022/240895A1 |
Various aspects of this disclosure relate to (1) methods to perform a ring contraction in the gas phase, (2) compositions obtainable by such methods, and (3) reaction vessels that contain compositions that comprise either a reactant or a...
|
WO/2022/226473A1 |
The present disclosure relates to synthetic methods for preparing a 9-alpha-substituted or a 9- beta-substituted steroid-like compound. In particular, the disclosure relates to methods for generating a steroidal C9-C10 bond and establish...
|
WO/2022/217063A1 |
Disclosed are amino-substituted, halomethylene-substituted cyclohexene carboxylic acid compounds and amino-substituted, halomethylene-substituted cyclohexane carboxylic acid compounds. The disclosed compounds and compositions thereof may...
|
WO/2022/210164A1 |
A purpose of the present invention is to provide a method for producing cyclopentene having excellent production stability that makes it possible to produce high-purity cyclopentene at a high yield. The method for producing cyclopentene ...
|
WO/2022/205543A1 |
Disclosed are a monodisperse polymer containing a fluorene-butadiyne structure in the main chain, and a preparation method therefor and the use thereof. The monodisperse polymer has a structure, as shown in formula I, and is prepared by ...
|
WO/2022/206829A1 |
The present application relates to the field of electroluminescence, and discloses a compound, an organic electroluminescent device and a display apparatus. The structural formulae of the compound are represented by formulae (I) to (III)...
|
WO/2022/210162A1 |
The purpose of the present invention is to provide: a catalyst that enables a gas-phase hydrogenation reaction from cyclopentadiene to cyclopentene and that exhibits both a high conversion and a high selectivity; and a method for produci...
|
WO/2022/185877A1 |
The present invention provides a method for efficiently producing a hydrogenated compound under mild conditions. A catalyst composition which contains a Lewis acid and a metal nanoparticle catalyst that is obtained by loading a carrier...
|
WO/2022/175112A1 |
The invention relates to a method for producing complexes of noble metals, in particular platinum, which have at least one organo-dihydroazulenyl ligand. The invention also relates to complexes of noble metals, in particular platinum, wh...
|
WO/2022/173899A1 |
This disclosure relates to compositions comprising diruthenium catalysts and uses related thereto. In certain embodiments, the diruthenium catalyst comprises a cyclopropyl ring substituted with a carboxylic acid ligand. In certain embodi...
|
WO/2022/165395A1 |
Stably consolidated compounds assembled from a statin and a metformin analog, and metabolically labile dual prodrugs assembled from the same, methods of making both, and methods of using them to treat metabolic diseases such as cancers a...
|
WO/2022/154048A1 |
A production method for indan and hydrindane, the method comprising: a reaction step for introducing a raw material composition containing tetrahydroindene into a continuous reaction vessel that includes a solid catalyst including platin...
|
WO/2022/147465A1 |
The present invention provides compounds, compositions thereof, and methods of using the same.
|
WO/2022/138746A1 |
A method for producing cyclopentadiene according to one aspect of the present disclosure includes a dehydrogenation step for obtaining cyclopentadiene by bringing a dehydrogenation catalyst into contact with a raw material component cont...
|
WO/2022/138860A1 |
A method for producing dicyclopentadiene according to one aspect of the present disclosure comprises: an isomerization dehydrocyclization step wherein cyclopentadiene is produced by subjecting a hydrocarbon mixture, which contains the no...
|
WO/2022/140555A1 |
Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.
|
WO/2022/138841A1 |
This method for manufacturing dicyclopentadiene and isoprene according to one aspect of the present disclosure comprises: a separation step in which a hydrocarbon mixture containing a normal form and an isoform of a hydrocarbon with a ca...
|
WO/2022/131888A1 |
The present invention relates to a method for preparing a catalyst for selective hydrogenation of cyclododecatriene, and a catalyst prepared by the preparation method. The method for preparing a catalyst for selective hydrogenation of cy...
|